VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594,814 | -18.9% | 22,104 | -9.3% | 0.04% | -18.4% |
| Q2 2023 | $733,836 | -21.0% | 24,372 | -15.1% | 0.05% | -23.4% |
| Q1 2023 | $928,616 | +8.6% | 28,705 | -3.8% | 0.06% | +6.7% |
| Q4 2022 | $854,940 | +23.9% | 29,830 | +4.3% | 0.06% | +13.2% |
| Q3 2022 | $690,000 | -3.9% | 28,613 | +9.1% | 0.05% | +1.9% |
| Q2 2022 | $718,000 | -15.4% | 26,220 | +18.4% | 0.05% | 0.0% |
| Q1 2022 | $849,000 | +10.0% | 22,143 | -8.1% | 0.05% | +10.6% |
| Q4 2021 | $772,000 | +8.3% | 24,103 | -1.2% | 0.05% | +4.4% |
| Q3 2021 | $713,000 | -14.2% | 24,393 | -0.2% | 0.04% | -22.4% |
| Q2 2021 | $831,000 | +19.9% | 24,443 | +14.2% | 0.06% | +9.4% |
| Q1 2021 | $693,000 | +5.6% | 21,410 | +17.8% | 0.05% | -3.6% |
| Q4 2020 | $656,000 | -5.3% | 18,169 | +2.7% | 0.06% | -15.4% |
| Q3 2020 | $693,000 | -1.3% | 17,686 | -7.2% | 0.06% | -13.3% |
| Q2 2020 | $702,000 | +108.3% | 19,066 | +30.4% | 0.08% | +53.1% |
| Q1 2020 | $337,000 | -42.5% | 14,616 | -27.3% | 0.05% | -16.9% |
| Q4 2019 | $586,000 | +28.8% | 20,116 | +18.4% | 0.06% | +18.0% |
| Q3 2019 | $455,000 | +8.1% | 16,988 | +4.1% | 0.05% | -5.7% |
| Q2 2019 | $421,000 | +14.7% | 16,323 | +0.1% | 0.05% | +6.0% |
| Q1 2019 | $367,000 | +16.1% | 16,303 | +7.4% | 0.05% | 0.0% |
| Q4 2018 | $316,000 | +6.8% | 15,173 | -4.4% | 0.05% | +38.9% |
| Q3 2018 | $296,000 | -17.5% | 15,873 | -0.9% | 0.04% | -25.0% |
| Q2 2018 | $359,000 | -28.2% | 16,013 | -29.5% | 0.05% | -27.3% |
| Q1 2018 | $500,000 | -24.2% | 22,728 | -20.2% | 0.07% | -24.1% |
| Q4 2017 | $660,000 | +3.8% | 28,487 | -5.7% | 0.09% | -5.4% |
| Q3 2017 | $636,000 | -0.3% | 30,200 | +4.9% | 0.09% | -13.2% |
| Q2 2017 | $638,000 | 0.0% | 28,800 | -18.8% | 0.11% | -0.9% |
| Q1 2017 | $638,000 | -30.0% | 35,455 | -34.5% | 0.11% | -28.7% |
| Q4 2016 | $911,000 | -60.3% | 54,114 | -37.6% | 0.15% | -60.9% |
| Q3 2016 | $2,294,000 | +0.6% | 86,763 | +5.4% | 0.38% | -4.2% |
| Q2 2016 | $2,280,000 | – | 82,340 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |